EMA
withdrawal
· 2008-05-23
EMA Application withdrawn: orBec (beclomethasone dipropionate) — DOR BIOPHARMA UK Ltd
Summary
The EMA withdrew the application for orBec (beclomethasone dipropionate) for graft-versus-host disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Application withdrawn. Therapeutic area: Graft vs Host Disease. MAH: DOR BIOPHARMA UK Ltd. Decision date: 31/12/2009. Orphan medicine